Cargando…
Suppression of microRNA-205-5p in human mesenchymal stem cells improves their therapeutic potential in treating diabetic foot disease
Diabetes is a prevalent disease endangering human health, while diabetic foot disease (DF) is one of the most severe complications of diabetes. Mesenchymal stem cells (MSCs) have been used in DF treatment, taking advantage of the differentiation potential of MSCs into endothelial cells and their pro...
Autores principales: | Zhu, Lingyan, Wang, Gongxian, Fischbach, Shane, Xiao, Xiangwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581029/ https://www.ncbi.nlm.nih.gov/pubmed/28881730 http://dx.doi.org/10.18632/oncotarget.17012 |
Ejemplares similares
-
Improved therapeutic effects on diabetic foot by human mesenchymal stem cells expressing MALAT1 as a sponge for microRNA-205-5p
por: Zhu, Lingyan, et al.
Publicado: (2019) -
MicroRNA‐205‐5p: A potential therapeutic target for influenza A
por: Bao, Yanyan, et al.
Publicado: (2022) -
Overexpression of microRNA-205-5p exerts suppressive effects on stem cell drug resistance in gallbladder cancer by down-regulating PRKCE
por: Zhang, Guo-Feng, et al.
Publicado: (2020) -
Oncosuppressive role of MicroRNA-205–3p in gastric cancer through inhibition of proliferation and induction of senescence: Oncosuppressive role of MicroRNA-205 in gastric cancer
por: Ma, Xiaoyu, et al.
Publicado: (2021) -
Human bone marrow mesenchymal stem cells-derived microRNA-205-containing exosomes impede the progression of prostate cancer through suppression of RHPN2
por: Jiang, Shuangjian, et al.
Publicado: (2019)